Guest guest Posted February 16, 2012 Report Share Posted February 16, 2012 FDA OKs prostate cancer assay from Gen-Probe Gen-Probe has secured FDA approval for PROGENSA PCA3, which is billed as the first molecular assay designed to help evaluate whether men who previously had negative prostate biopsies need to undergo a repeat biopsy. Reuters (2/15)      Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.